• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SUNEVA MEDICAL, INC. BELLAFILL DERMAL FILLER IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SUNEVA MEDICAL, INC. BELLAFILL DERMAL FILLER IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Model Number GBF0508 (SUSPECTED)
Device Problem Use of Device Problem (1670)
Patient Problems Unspecified Infection (1930); Patient Problem/Medical Problem (2688)
Event Type  Injury  
Manufacturer Narrative
Doctor reports infection with a patient that was injected with bellafill by another doctor off-label on the cheeks. The patient was treated with antibiotics. Bellafill use has not been confirmed. It is unknown at this time if medical intervention was required to prevent permanent impairment or damage. Rationale for delayed submission of this mdr: at the time of report receipt on 06/09/2020, suneva had determined that an mdr was not required; however subsequent review found that a conservative mdr was warranted, as it is unknown at this time if medical intervention was required to prevent permanent impairment or damage, however it is implied. Timeline: initial report on 06/09/2020: sales rep relayed that dr. (b)(6) (not the injector) has a patient who says she had an infection from bellafill. 06/10/2020: the doctor relayed that the patient was injected in multiple areas and one area on the cheek developed an infection. The patient had been treated with antibiotics and drainage from the area, and the infection had settled. The patient was now presenting with a firm nodule in the same area. 07/24/2020: additional information was requested from the account, including current patient status and name of the facility where the patient was injected. 08/03/2020: no response from the account. A reminder was sent for the requested additional information. A follow up mdr will be filed once any updates are received. The bellafill injector is unknown. The bellafill lot used in the patient's procedure is unknown. Bellafill use cannot be confirmed at this time. Bellafill dermal filler is indicated for the correction of nasolabial folds and moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years. The bellafill ifu contains the following precaution: "as with all transcutaneous procedures, bellafill injection carries a risk of infection. The usual precautions associated with injectable materials should be followed. " nodules are anticipated patient events that are documented in the bellafill ifu. Clinical studies support that nodules may resolve over time with or without treatment. Bellafill syringes are single use devices and are typically discarded after use. Per the bellafill ifu: "the syringe and any unused material should be discarded after a single treatment visit. ".
 
Event Description
Doctor reports infection with a patient that was injected with bellafill by another doctor off-label in the cheeks. The patient was treated with antibiotics. Bellafill use has not been confirmed. It is unknown at this time if medical intervention was required to prevent permanent impairment or damage.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameBELLAFILL DERMAL FILLER
Type of DeviceIMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
SUNEVA MEDICAL, INC.
5870 pacific center blvd.
san diego, ca
Manufacturer (Section G)
SUNEVA MEDICAL, INC.
5870 pacific center blvd.
san diego, ca
Manufacturer Contact
stacy lewis
5870 pacific center blvd.
san diego, ca 
7685492
MDR Report Key10358193
MDR Text Key203290716
Report Number3003707320-2020-00008
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020012
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation
Type of Report Initial
Report Date 08/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/03/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Device Model NumberGBF0508 (SUSPECTED)
Device Catalogue NumberGBF0508 (SUSPECTED)
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received06/09/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient Treatment Data
Date Received: 08/03/2020 Patient Sequence Number: 1
-
-